Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders.
Endocr Metab Immune Disord Drug Targets. 2021;21(5):777-784. doi: 10.2174/1871530320666200729142504.
Endocr Metab Immune Disord Drug Targets. 2021.
PMID: 32727337
Review.